You are here
- Home
- Last 30 days trials
Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients
- Disease
- diabetes mellitus
- Drug Name
- dapagliflozin
- Generic Name
- Dapagliflozin
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- I
- Start Date
- Jan 1, 2010
- Study Name
- D1692C00002
- Study Id
- D1692C00002
- ClinicalTrials.gov ID
- NCT01055652
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Aug 16, 2010
- D1692C00002.pdf (494 KB)
